{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:15:50Z","timestamp":1767899750008,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jcin.2016.10.019","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T16:30:56Z","timestamp":1482337856000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold\u00a0for Treatment of Patients\u00a0With\u00a0Diabetes Mellitus"],"prefix":"10.1016","volume":"10","author":[{"given":"Dean J.","family":"Kereiakes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Veldhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Thien","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2016.10.019_bib1","doi-asserted-by":"crossref","first-page":"e002328","DOI":"10.1161\/CIRCINTERVENTIONS.114.002328","article-title":"High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry","volume":"8","author":"Ritsinger","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.10.019_bib2","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.CIR.0000131898.18849.65","article-title":"Clinical and angiographic predictors of restenosis after percutaneous coronary intervention","volume":"109","author":"Singh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","article-title":"Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus","volume":"124","author":"Stone","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0735-1097(02)01971-X","article-title":"Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients","volume":"40","author":"Van Belle","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib5","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","article-title":"Diabetes mellitus and thrombosis","volume":"129","author":"Vazzana","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jcin.2016.10.019_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.amjcard.2010.06.042","article-title":"Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)","volume":"106","author":"Akin","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib8","first-page":"246","article-title":"Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes","volume":"147","author":"McGuire","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2016.10.019_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2003.06.019","article-title":"Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention","volume":"43","author":"Corpus","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-8703(03)00235-7","article-title":"Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention","volume":"146","author":"Muhlestein","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2016.10.019_bib11","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jacc.2012.08.993","article-title":"Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008","volume":"60","author":"Hillegass","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.amjcard.2008.07.012","article-title":"Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus","volume":"102","author":"Patti","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds evidence from a network meta-analysis of 147 trials","volume":"9","author":"Kang","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.10.019_bib14","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2016.02.025","article-title":"Incidence and clinical outcomes of stent fractures on the basis of 6,555 Patients and 16,482 drug-eluting stents from 4 centers","volume":"9","author":"Kan","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.10.019_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib17","doi-asserted-by":"crossref","first-page":"e002230","DOI":"10.1161\/CIRCINTERVENTIONS.114.002230","article-title":"Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE All-Comers trial","volume":"8","author":"Iqbal","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.10.019_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/CIRCINTERVENTIONS.110.958249","article-title":"Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation","volume":"3","author":"Yamaji","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.10.019_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","article-title":"Bioresorbable vascular scaffolds for coronary revascularization","volume":"134","author":"Kereiakes","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.10.019_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2016.10.019_bib21","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A\u00a0randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.10.019_bib22","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.10.019_bib23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled","volume":"10","author":"Abizaid","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.10.019_bib24","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","article-title":"Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)","volume":"56","author":"Kereiakes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib25","unstructured":"Food and Drug Administration. Guidelines for\u00a0Industry: Non-Inferiority Clinical Trials. March 2010. Available at: http:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-drugs-gen\/documents\/document\/ucm202140.pdf. Accessed September 20, 2016."},{"key":"10.1016\/j.jcin.2016.10.019_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of Martingale-based residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.jcin.2016.10.019_bib27","series-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1016\/j.jcin.2016.10.019_bib28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"13_S","key":"10.1016\/j.jcin.2016.10.019_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0735-1097(16)30036-5","article-title":"Outcomes of the Absorb bioresorbable vascular scaffold in very small and not very small coronary arteries: the ABSORB III randomized trial","volume":"67","author":"Stone","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.10.019_bib31","series-title":"Bioresorbable Vascular Scaffold (BVS) System Instructions for Use","author":"Absorb","year":"2016"},{"key":"10.1016\/j.jcin.2016.10.019_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcin.2014.01.155","article-title":"1-Year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials","volume":"7","author":"Muramatsu","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816318416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816318416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:04Z","timestamp":1761847444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816318416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1936879816318416"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2016.10.019","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold\u00a0for Treatment of Patients\u00a0With\u00a0Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2016.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}